SCHEMBL19420154

SCHEMBL19420154

O=C(O)CCCCCN1C(=O)/C(=C/c2cccs2)SC1=S

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 3/20 1.00
▸ MAPT P10636 8/20 0.69
▸ KDM4E B2RXH2 5/20 0.69
▸ LMNA P02545 1/20 0.69
▸ THRB P10828 1/20 0.69
▸ KMT2A Q03164 8/20 0.64
▸ MEN1 O00255 6/20 0.64
▸ ALDH1A1 P00352 1/20 0.64
▸ GPR55 Q9Y2T6 2/20 0.64
▸ NPC1 O15118 1/20 0.64
▸ DNMT1 P26358 2/20 0.62
▸ PKM P14618 1/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ BLM P54132 1/20 0.62
▸ MCL1 Q07820 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ PSMD14 O00487 1/20 0.62
▸ MMP2 P08253 1/20 0.62
▸ POLB P06746 2/20 0.62
▸ GAA P10253 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12006896 0.95 FFAR1 (1.00) FFAR1MAPTKDM4ELMNAKMT2A
SCHEMBL12008950 0.91 FFAR1 (0.86) FFAR1MAPTKDM4ELMNAKMT2A
SCHEMBL29215003 0.88 FFAR1 (0.79) FFAR1MAPTKDM4ELMNATHRB
SCHEMBL29215005 0.88 FFAR1 (0.79) FFAR1MAPTKDM4ELMNATHRB
SCHEMBL12009676 0.86 FFAR1 (0.83) FFAR1MAPTKDM4ELMNAKMT2A
SCHEMBL12006886 0.85 FFAR1 (0.81) FFAR1MAPTLMNAKMT2AMEN1
SCHEMBL12008981 0.83 FFAR1 (0.78) FFAR1MAPTLMNATHRBKMT2A
SCHEMBL10464668 0.83 FFAR1 (0.74) FFAR1MAPTKDM4ELMNAKMT2A
SCHEMBL6885407 0.83 FFAR1 (0.74) FFAR1MAPTKDM4ELMNAKMT2A
SCHEMBL6885409 0.83 FFAR1 (0.74) FFAR1MAPTKDM4ELMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease UNITY BIOTECHNOLOGY, INC. (US) 2019-02-05 — — US disclosed
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 — — US disclosed
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES TP53, NQO1, SHMT2 FFAR1 4000/4885MAPT 1762/4885KDM4E 3258/4885
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease TP53, CDKN1A, GLA FFAR1 4130/4885MAPT 1460/4885KDM4E 2184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback